Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

737.05INR
6:17am EDT
Change (% chg)

Rs-29.40 (-3.84%)
Prev Close
Rs766.45
Open
Rs769.95
Day's High
Rs770.40
Day's Low
Rs732.00
Volume
305,528
Avg. Vol
305,873
52-wk High
Rs933.70
52-wk Low
Rs706.40

Latest Key Developments (Source: Significant Developments)

Taro Pharma CEO Kal Sundaram to return to Sun Pharma headquarters by the end of 2016
Wednesday, 6 Jul 2016 05:02pm EDT 

Taro Pharmaceutical Industries Ltd : Taro ceo Kal Sundaram to return to Sun Pharma headquarters by the end of 2016 . Sundaram informed taro's board of his intention to step down as ceo by end of current calendar year .Board will conduct a formal process to appoint a ceo for taro.  Full Article

Sun Pharma Industries approves buyback of 7.5 mln shares at 900 rupees/share
Monday, 27 Jun 2016 09:21am EDT 

Sun Pharmaceutical Industries Ltd :Approved buyback of 7.5 million shares at 900 rupees/share.  Full Article

Sun Pharmaceutical Industries approves buyback of equity shares
Thursday, 23 Jun 2016 10:33pm EDT 

Sun Pharmaceutical Industries Ltd : Board approves buyback of equity shares . Approved the buyback by the company of its fully paid up equity shares worth inr 6.75 billion .  Full Article

Sun Pharmaceutical Industries says co expects FY17 sales up 8-10 pct
Monday, 30 May 2016 11:34pm EDT 

Sun Pharmaceutical Industries Ltd : MD says expects FY 2017 sales up 8-10 percent . Exec says Department of Justice subpoena is "not a product specific query" . Further company coverage [SUN.NS] ((Bengaluru Newsroom; +91 80 6749 1130)).  Full Article

Sun Pharmaceutical Industries March-qtr consol profit 17.14 bln rupees
Monday, 30 May 2016 10:55pm EDT 

Sun Pharmaceutical Industries Ltd : March-quarter consol net profit 17.14 billion rupees .  Full Article

Sun Pharmaceutical Industries Ltd falls; recalls osteoporosis drugs in U.S. - Reuters News
Thursday, 10 Mar 2016 12:46pm EST 

Sun Pharmaceutical Industries Ltd:Sun Pharmaceuticals SUN.NS falls as much as 2.5 pct - RTRS.India's largest drug maker voluntarily recalls 381,120 cartons of osteoporosis drugs in the U.S. and Puerto Rico - U.S. FDA website."Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point" - FDA on recall reason.Drug was manufactured at Sun Pharma's Halol plant in Gujarat - FDA.FDA had warned Sun Pharma over standards at Halol plant in December.  Full Article

Sun Pharmaceutical Industries Ltd slumps after US issues new reprimand to India drug industry - Reuters
Sunday, 20 Dec 2015 02:47pm EST 

Sun Pharmaceutical Industries Ltd:Sun Pharmaceutical Industries Ltd SUN.BO, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry. - RTRS.The warning comes barely a month after rival Dr Reddy's Laboratories Ltd REDY.NS was reprimanded by the U.S. Food and Drug Administration for issues including record-keeping at three of its plants. - RTRS.The company said it was working to resolve the FDA's lingering concerns about the Halol plant, disclosed in a statement by Sun Pharma on Saturday - RTRS.Since then, the FDA has also significantly scaled up inspections of foreign plants, leading to a series of warnings and import bans on manufacturing plants in India over problems ranging from compromising data to hygiene and repair issues - RTRS.The latest warning increases the risk the FDA may ban imports from the Halol plant altogether, which would hit Sun Pharma's U.S. sales, about 15 percent of which come from the plant in question. - RTRS.  Full Article

Sun Pharmaceutical Industries Ltd announces research collaboration with Weizmann Institute of Science, Israel & Health Research Institute of Santiago, Spain for brain therapies
Wednesday, 9 Dec 2015 09:34pm EST 

Sun Pharmaceutical Industries Ltd:Says that it has entered into a tripartite research and option agreement with Israel-based Weizmann Institute of Science and Spain's Health Research Institute of Santiago de Compostela (IDIS) to develop products for treatment of neurological diseases like brain stroke; as well as glioblastoma.Scientists at Weizmann Institute have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma.Says that as per the signed triparty agreement, Sun Pharma will have the first right to develop these additional indications.  Full Article

Sun Pharmaceutical Industries Ltd completes of acquisition of Insite Vision Inc
Monday, 2 Nov 2015 10:35pm EST 

Sun Pharmaceutical Industries Ltd:Says completion of acquisition of Insite Vision Inc.  Full Article

Sun Pharmaceutical Industries Ltd recalls anti-allergic drug in US - Times of India
Tuesday, 27 Oct 2015 10:33pm EDT 

Sun Pharmaceutical Industries Ltd:Sun Pharma has initiated a recall of over a million packs of anti-allergic Loratadine drug from the US market after checks reportedly revealed the tablets were 'super potent' and 'out of specification' - Times of India.Loratadine tablets are manufactured and distributed in the US market by Ohm Laboratories, US-based subsidiary of Ranbaxy. Loratadine is generic version of Bayer's Claritin drug - Times of India.Sun Pharma acquired Ranbaxy in a $4 billion deal in April 2014, making it the largest domestic pharma company by sales - Times of India.  Full Article

EU court to rule on drugmaker Lundbeck's pay-for-delay deals

Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.